Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "STADA Aktie Wieder Fundamentaldaten schauen Aktienanalyse" found in our extensive corporate database of over 50,000 company records.
STADA - Generics with “value for money” Generics contributed 73.2% to sales in 2006 (previous year: 74.3%) and represents STADA’s largest core segment by far. In 2006, sales in the generics core segment rose by 20% to EUR 911.2 million (2005: EUR 759.3 million1)). A part of this growth is based on the acquisition of the Serbian Hemofarm, whose product portfolio includes approx. 75% of gener...